Erigeron breviscapus extraction dry suspensoid agent
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FUDAN UNIV
- Publication Date
- 2005-01-05
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the field of pharmaceutical preparations, and relates to a pharmaceutical preparation for treating cardiovascular and cerebrovascular diseases. It specifically relates to a dry suspension containing breviscapine. Background technique
[0002] Brevescapine (Brevescapine) is a class of flavonoids isolated from the Asteraceae plant (formerly known as Dengzhanhua, also known as Dengzhan Asarum, Erigeron Breviscapus (Vant.) Hand.-Mazz.), mainly containing Scutellarin (chemical name 4', 5, 6-trihydroxyflavonoid-7-glucuronide) also contains a small amount of scutellarin and other flavonoids.
[0003] Existing pharmacodynamic studies have shown that breviscapine can dilate cerebral blood vessels, reduce cerebrovascular resistance, increase cerebral blood flow, improve microcirculation, improve blood-brain barrier permeability, enhance the phagocytic immune function of macrophages, and fight against the pituitary gland. Vasoline-induc...